MiniMed (MMED) Asset Writedowns and Impairment (2025 - 2026)
MiniMed (MMED) posted Asset Writedowns and Impairment of $6.0 million for Q3 2026, up 100.0% quarter-over-quarter from $3.0 million in Q3 2025, and up 100.0% YoY from $3.0 million in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Asset Writedowns and Impairment (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Asset Writedowns and Impairment data on file, last reported at $6.0 million in Q3 2026.
- For the quarter ending Q3 2026, Asset Writedowns and Impairment rose 100.0% year-over-year to $6.0 million; the trailing twelve-month figure through Jul 2026 stood at $17.0 million (changed N/A YoY), and the FY2026 full-year result was $84.0 million, up 300.0% from the prior year.
- Asset Writedowns and Impairment was $6.0 million for Q3 2026 at MiniMed, up from $3.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $8.0 million in Q2 2025 to a low of $3.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | MiniMed | 6.55 Bn | 6.34 Bn | 465.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 6.00 Mn |
| Jul 25, 2025 | 3.00 Mn |
| Apr 25, 2025 | 8.00 Mn |